GI
TARA icon

GAMMA Investing’s Protara Therapeutics TARA Stock Holding History

GAMMA Investing’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.08K Sell
682
-50
-7% -$195 ﹤0.01% 3945
2026
Q2 		$2.8K Buy
732
+155
+27% +$737 ﹤0.01% 3663
2026
Q1 		$3.01K Buy
+577
New +$3.42K ﹤0.01% 3547

Other funds holding TARA

EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's TARA Position: Q3 2026 in Review

GAMMA Investing reduced its Protara Therapeutics (TARA) stake by 6.8% in Q3 2026, selling an estimated $195 and leaving 682 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3945.

GAMMA Investing first reported a position in TARA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.01K in Q1 2026. 3 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

  • GAMMA Investing held 682 shares of Protara Therapeutics worth $2.08K as of Q3 2026.
  • GAMMA Investing sold 50 Protara Therapeutics shares in Q3 2026, an estimated $195.
  • Protara Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3945 holding.
  • GAMMA Investing first reported a position in Protara Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • GAMMA Investing's Protara Therapeutics position peaked at $3.01K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.